MX2019002183A - Metodo de produccion de proteinas. - Google Patents

Metodo de produccion de proteinas.

Info

Publication number
MX2019002183A
MX2019002183A MX2019002183A MX2019002183A MX2019002183A MX 2019002183 A MX2019002183 A MX 2019002183A MX 2019002183 A MX2019002183 A MX 2019002183A MX 2019002183 A MX2019002183 A MX 2019002183A MX 2019002183 A MX2019002183 A MX 2019002183A
Authority
MX
Mexico
Prior art keywords
production method
protein production
folded protein
etanercept
titers
Prior art date
Application number
MX2019002183A
Other languages
English (en)
Inventor
Puchacz Ela
Russel Grove James
Original Assignee
Coherus Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coherus Biosciences Inc filed Critical Coherus Biosciences Inc
Publication of MX2019002183A publication Critical patent/MX2019002183A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Wood Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)

Abstract

La produccion de etanercept usando metodos de perfusion logra rendimientos atractivos de proteina correctamente plegada; se describen temperatura deseada, medio de alimento, titulos y porcentaje de proteina correctamente plegada.
MX2019002183A 2013-03-26 2015-09-25 Metodo de produccion de proteinas. MX2019002183A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361805215P 2013-03-26 2013-03-26
US201461933665P 2014-01-30 2014-01-30

Publications (1)

Publication Number Publication Date
MX2019002183A true MX2019002183A (es) 2019-05-16

Family

ID=51621470

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015013668A MX362922B (es) 2013-03-26 2014-03-26 Método de producción de proteínas.
MX2019002183A MX2019002183A (es) 2013-03-26 2015-09-25 Metodo de produccion de proteinas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015013668A MX362922B (es) 2013-03-26 2014-03-26 Método de producción de proteínas.

Country Status (12)

Country Link
US (2) US9765139B2 (es)
EP (2) EP2978498B1 (es)
JP (2) JP6689189B2 (es)
KR (1) KR20150133833A (es)
AU (2) AU2014241259B9 (es)
BR (1) BR112015024755A2 (es)
CA (1) CA2907771C (es)
HK (1) HK1218893A1 (es)
MX (2) MX362922B (es)
RS (1) RS59328B1 (es)
SG (2) SG10201802023RA (es)
WO (1) WO2014160790A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
EP3209311B1 (en) 2014-10-21 2024-03-06 University of Massachusetts Recombinant aav variants and uses thereof
KR101936049B1 (ko) 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
AU2017341849B2 (en) 2016-10-13 2024-03-21 University Of Massachusetts AAV capsid designs
MA50911A (fr) * 2017-11-13 2020-09-23 Amgen Inc Procédés de production de produits protéiniques
CN109971705A (zh) * 2019-04-16 2019-07-05 上海汉尼生物细胞技术有限公司 一种cho dg44细胞培养基添加物及其制备方法
JP2024503239A (ja) * 2020-12-22 2024-01-25 アムジェン インコーポレイテッド 細胞培養法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817235A (en) 1954-03-22 1957-12-24 Phillips Petroleum Co Temperature measuring system for underground storage cavern
US2893211A (en) 1955-05-16 1959-07-07 Phillips Petroleum Co Underground storage system
US3064436A (en) 1955-10-27 1962-11-20 Robert L Loofbourow Sealing underground cavities
DE1126800B (de) 1958-03-17 1962-03-29 Stamicarbon Vorrichtung zum Hinaufbefoerdern grobkoernigen Gutes, wie Erz und Kohle, aus grosser Teufe, z.B. aus einer Zeche od. dgl., mittels einer Transportfluessigkeit
US3068654A (en) 1958-09-22 1962-12-18 Interstate Service Corp Underground storage cavern and method of making same
US3184922A (en) 1960-07-12 1965-05-25 Suburban Propane Gas Corp Method of and means for storing liquefied petroleum gases underground
US4011736A (en) 1975-11-12 1977-03-15 Halm Instrument Co., Inc. Cold storage tank
FR2372751A1 (fr) 1976-12-02 1978-06-30 Commissariat Energie Atomique Reservoir souterrain pour fluides sous pression
SE450509B (sv) 1981-08-07 1987-06-29 Karl Ivar Sagefors Metod att bygga en anleggning for lagring av flytande produkter i berg
US4701280A (en) 1982-06-09 1987-10-20 John Canevall Procedure for permanently storing radioactive material
US4488834A (en) 1982-11-17 1984-12-18 Empak, Inc. Method for using salt deposits for storage
FR2545067B1 (fr) 1983-04-26 1987-08-07 Geostock Procede et dispositif de stockage souterrain d'ammoniac et produits analogues
US5207530A (en) 1992-07-29 1993-05-04 Halliburton Company Underground compressed natural gas storage and service system
US7294481B1 (en) * 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
US6261805B1 (en) 1999-07-15 2001-07-17 Boyce Thompson Institute For Plant Research, Inc. Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
US6826911B2 (en) 2001-03-12 2004-12-07 Pomfret Storage Company, Llc Storage of energy producing fluids and process thereof
PT1543106E (pt) 2002-07-15 2007-05-31 Immunex Corp Métodos e meios para controlar a sialilação de proteínas produzidas por células de mamíferos
EP2308958A3 (en) * 2004-03-05 2011-08-10 DSM IP Assets B.V. Process for cell culturing by continuous perfusion and alternating tangential flow
TWI364458B (en) 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
US7691611B2 (en) * 2005-06-03 2010-04-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
EP4155385A1 (en) * 2005-12-08 2023-03-29 Amgen Inc. Improved production of glycoproteins using manganese
AU2008223133A1 (en) * 2007-03-02 2008-09-12 Wyeth Use of copper and glutamate in cell culture for production of polypeptides
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
EP2014760A1 (en) * 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
US20120329709A1 (en) * 2009-05-26 2012-12-27 Brian Edward Collins Production of glycoproteins
US9540426B2 (en) 2009-10-06 2017-01-10 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
WO2011116148A2 (en) 2010-03-16 2011-09-22 Dana Todd C Systems, apparatus and methods for extraction of hydrocarbons from organic materials
CN102382794B (zh) * 2010-09-01 2013-09-18 山东新时代药业有限公司 一种哺乳动物细胞的灌流培养方法
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
KR102558247B1 (ko) * 2011-07-01 2023-07-24 암젠 인크 포유동물 세포 배양
JP6280499B2 (ja) * 2011-07-08 2018-02-14 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｆｃ融合タンパク質の精製方法

Also Published As

Publication number Publication date
CA2907771A1 (en) 2014-10-02
EP2978498A1 (en) 2016-02-03
AU2014241259A1 (en) 2015-10-22
HK1218893A1 (zh) 2017-03-17
MX2015013668A (es) 2016-06-28
JP2020073503A (ja) 2020-05-14
US20140296489A1 (en) 2014-10-02
JP2016514475A (ja) 2016-05-23
US20160122427A1 (en) 2016-05-05
RS59328B1 (sr) 2019-10-31
AU2019201129B2 (en) 2020-12-24
AU2014241259B2 (en) 2018-12-06
WO2014160790A1 (en) 2014-10-02
US9765139B2 (en) 2017-09-19
AU2014241259B9 (en) 2018-12-20
CA2907771C (en) 2023-01-10
MX362922B (es) 2019-02-25
EP3391942A1 (en) 2018-10-24
JP6689189B2 (ja) 2020-04-28
AU2019201129A1 (en) 2019-03-07
SG10201802023RA (en) 2018-05-30
BR112015024755A2 (pt) 2017-07-18
KR20150133833A (ko) 2015-11-30
EP2978498B1 (en) 2019-07-03
EP2978498A4 (en) 2016-10-05
SG11201507875RA (en) 2015-10-29
US10975138B2 (en) 2021-04-13

Similar Documents

Publication Publication Date Title
MX2019002183A (es) Metodo de produccion de proteinas.
EP3313863A4 (en) DEGRON FUSION CONSTRUCTS AND METHODS OF REGULATING PROTEIN PRODUCTION
ZA201802657B (en) Crystal forms of beta-nicotinamide mononucleotide
MX2018015853A (es) Anticuerpos multiespecificos frente a los grupos de diferenciacion 40 y 137 (cd40 y cd137).
EP3297451A4 (en) Gas fermentation for the production of protein or feed
EP3030670A4 (en) Solid state fermentation systems and process for producing high-quality protein concentrate and lipids
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
HK1249764A1 (zh) 產生l-亮氨酸的微生物以及使用其產生l-亮氨酸的方法
EP3385305A4 (en) PROCESS FOR PRODUCING A PROTEIN SOLUTION
EP4353316A3 (en) Rsv-specific antibodies and functional parts thereof
MX2020001357A (es) Produccion microbiana de aminas grasas.
PL2960326T3 (pl) Mikroorganizm zdolny do zwiększenia wytwarzania kwasu mlekowego i sposób wytwarzania kwasu mlekowego przy jego użyciu
EP3162895A4 (en) Improved fc-binding protein, method for producing said protein, antibody adsorbent using said protein, and method for separating antibody using said adsorbent
HUE048901T2 (hu) Fokozott L-lizin termelésû mikroorganizmus és eljárás L-lizin elõállítására annak alkalmazásával
EP3318637A4 (en) Microorganism having l-lysine productivity and method for producing l-lysine by using same
MX2019002223A (es) Procedimiento mejorado para el cultivo de algas.
EP3181686A4 (en) Culture medium and method for enriching and maintaining cancer stem cells (cscs) using said medium
EP3048172A4 (en) Method for producing l-amino acid from seaweed-derived biomass
EP2987854A4 (en) MICROORGANISMS PRODUCING L-TRYPTOPHAN AND PROCESS FOR PRODUCING L-TRYPTOPHANE USING THE SAME
EP3098313A4 (en) Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid
MX2019002182A (es) Medios de perfusion.
EP3549946A4 (en) COMPOSITION OF PROTEIN, ITS PRODUCTION PROCESS AND PROCESS FOR IMPROVING THERMAL STABILITY
EP3305760A4 (en) METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND INTERMEDIATE FOR PRODUCING ALKYLAMINE DERIVATIVE
EP3255150A4 (en) Microorganism capable of producing quinolinic acid, and method for producing quinolinic acid utilizing the microorganism
EP3042911A4 (en) Method for producing dipeptide derivative containing disubstituted amino acid residue